New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2025, Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage
View latest version (2025)Bibliographic information
GuidelineWHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee, second edition. Geneva: World Health Organization; 2025
Year of Publication2023
Issuing InstitutionWHO
Recommendation
Retired
The use of a fixed-dose combination of oxytocin and ergometrine (5 IU/500 µg, IM) is recommended for the prevention of postpartum haemorrhage in contexts where hypertensive disorders can be safely excluded prior to its use
Context specific recommendation
Only in specific contexts
Certainty of evidence
Moderate